Trials / Completed
CompletedNCT02530944
Web-based Genetic Research on Lupus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (actual)
- Sponsor
- 23andMe, Inc. · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this new lupus research study is two-fold: first, to understand the genetic associations found between people's DNA and this disease, and second, to apply this understanding to drug development efforts with the investigator's partners at Pfizer.
Detailed description
Lupus is a difficult disease to diagnose and one that's difficult to manage, given the lack of specific medicines to treat lupus and the side-effects of current medications. The investigators believe genetics may play a critical role in developing better lupus diagnoses and treatments. If individuals are eligible to participate, the investigators will send a 23andMe DNA saliva kit at no cost. Participants will be asked to take a 15 minute online survey with questions about their lupus experience, symptoms and response to treatments, in addition to five additional bi-monthly short surveys and one final study survey during the 12-month participation. Learn more and join the lupus study today: https://www.23andme.com/lupus/
Conditions
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2017-10-31
- Completion
- 2017-10-31
- First posted
- 2015-08-21
- Last updated
- 2018-01-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02530944. Inclusion in this directory is not an endorsement.